Logo image
Phytoconstituents with cardioprotective properties: A pharmacological overview on their efficacy against myocardial infarction
Journal article   Peer reviewed

Phytoconstituents with cardioprotective properties: A pharmacological overview on their efficacy against myocardial infarction

Aman Ullah, Nada M Mostafa, Sobia Ahsan Halim, Esraa A Elhawary, Ain Ali, Rohail Bhatti, Usman Shareef, Waiel Al Naeem, Asaad Khalid, Hamdy Kashtoh, …
Phytotherapy research, v 38(9), pp 4467-4501
Sep 2024
PMID: 39023299

Abstract

Animals Anti-Inflammatory Agents - chemistry Anti-Inflammatory Agents - pharmacology Antioxidants - chemistry Antioxidants - pharmacology Cardiotonic Agents - chemistry Cardiotonic Agents - pharmacology Humans Myocardial Infarction - drug therapy Phytochemicals - chemistry Phytochemicals - pharmacology Phytotherapy Plant Extracts - chemistry Plant Extracts - pharmacology
Myocardial infarction (MI) is considered one of the most common cardiac diseases and major cause of death worldwide. The prevalence of MI and MI-associated mortality have been increasing in recent years due to poor lifestyle habits viz. residency, obesity, stress, and pollution. Synthetic drugs for the treatment of MI provide good chance of survival; however, the demand to search more safe, effective, and natural drugs is increasing. Plants provide fruitful sources for powerful antioxidant and anti-inflammatory agents for prevention and/or treatment of MI. However, many plant extracts lack exact information about their possible dosage, toxicity and drug interactions which may hinder their usefulness as potential treatment options. Phytoconstituents play cardioprotective role by either acting as a prophylactic or adjuvant therapy to the concurrently used synthetic drugs to decrease the dosage or relief the side effects of such drugs. This review highlights the role of different herbal formulations, examples of plant extracts and types of several isolated phytoconstituents (phenolic acids, flavonoids, stilbenes, alkaloids, phenyl propanoids) in the prevention of MI with reported activities. Moreover, their possible mechanisms of action are also discussed to guide future research for the development of safer substitutes to manage MI.

Metrics

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Chemistry, Medicinal
Pharmacology & Pharmacy
Logo image